Brenner Randall B. 4
4 · Paratek Pharmaceuticals, Inc. · Filed Oct 27, 2022
Insider Transaction Report
Form 4
Brenner Randall B.
Chief Development & Regulatory
Transactions
- Award
Common Stock
2022-10-25+8,500→ 357,649 total
Footnotes (1)
- [F1]Represents performance-based restricted stock units ("PRSUs") granted on February 26, 2019 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on October 25, 2022.